The 2016 meeting of the HTAi Asia Policy Forum meeting was held in Kuala Lumpur, 17th -18th November 2016. The topic of the meeting was: Assessing Value, Budget Impact and Affordability to Inform Discussions on Access and Reimbursement: Principles and Practice, with Special Reference to High Cost Technologies. This report represents the background paper for the meeting, as developed by OHE.

The paper begins with a discussion of how value can be defined, measured and factored into decisions on access and coverage.

Next, the paper looks at how budget impact and affordability can be defined and measured: we explain how different countries have adopted different approaches to how and when budget impact has been included within the decision making process, and outline several different scenarios around affordability challenges.

The final section considers whether high cost interventions call for new approaches to assessment and/or reimbursement, drawing on the recent high profile example of Sovaldi for the treatment of Hepatitis C.

The background papers from the 2013, 2014 and 2015 meeting are also available.

Please note a report of this meeting has also been published in the International Journal of Technology Assessment in Health Care.